BACKGROUND: The potential benefits and risks of the use of dual antiplatelet therapy beyond a 12-month period in patients receiving drug-eluting stents have not been clearly established. METHODS: In two trials, we randomly assigned a total of 2701 patients who had received drug-eluting stents and ha...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!